Get started
Anika Therapeutics Inc.Anika Therapeutics Inc.Anika Therapeutics Inc.

Anika Therapeutics Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ANIK chart


Full chart

ANIK upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪237.84 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6.64 USD
Net income (FY)
‪−82.67 M‬ USD
Revenue (FY)
‪166.66 M‬ USD
Shares float
‪14.13 M‬
Beta (1Y)
0.89

Employees


Employees (FY)
357
Change (1Y)
+12 +3.48%
Revenue / Employee (1Y)
‪466.84 K‬ USD
Net income / Employee (1Y)
‪−231.56 K‬ USD

About Anika Therapeutics Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Cheryl Renee Blanchard
Website
anika.com
Headquarters
Bedford
Founded
1992
FIGI
BBG000BBKZD8
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ANIK news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ANIK is 16.15 USD — it has increased by 0.71% in the past 24 hours. Watch Anika Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Anika Therapeutics Inc. stocks are traded under the ticker ANIK.
ANIK stock has risen by 0.65% compared to the previous week, the month change is a −8.32% fall, over the last year Anika Therapeutics Inc. has showed a −27.54% decrease.
We've gathered analysts' opinions on Anika Therapeutics Inc. future price: according to them, ANIK price has a max estimate of 28.00 USD and a min estimate of 25.00 USD. Watch ANIK chart and read a more detailed Anika Therapeutics Inc. stock forecast: see what analysts think of Anika Therapeutics Inc. and suggest that you do with its stocks.
ANIK reached its all-time high on Oct 25, 2019 with the price of 75.72 USD, and its all-time low was 0.69 USD and was reached on Dec 29, 2000. View more price dynamics on ANIK chart.
See other stocks reaching their highest and lowest prices.
ANIK stock is 2.11% volatile and has beta coefficient of 0.89. Track Anika Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Anika Therapeutics Inc. there?
Today Anika Therapeutics Inc. has the market capitalization of ‪237.84 M‬, it has increased by 1.81% over the last week.
Yes, you can track Anika Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Anika Therapeutics Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ANIK earnings for the last quarter are −0.25 USD per share, whereas the estimation was 0.09 USD resulting in a −377.78% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about Anika Therapeutics Inc. earnings.
Anika Therapeutics Inc. revenue for the last quarter amounts to ‪38.75 M‬ USD, despite the estimated figure of ‪42.08 M‬ USD. In the next quarter, revenue is expected to reach ‪29.00 M‬ USD.
ANIK net income for the last quarter is ‪−29.92 M‬ USD, while the quarter before that showed ‪−88.00 K‬ USD of net income which accounts for ‪−33.90 K‬% change. Track more Anika Therapeutics Inc. financial stats to get the full picture.
No, ANIK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 357.00 employees. See our rating of the largest employees — is Anika Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Anika Therapeutics Inc. EBITDA is ‪−20.97 M‬ USD, and current EBITDA margin is 1.07%. See more stats in Anika Therapeutics Inc. financial statements.
Like other stocks, ANIK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Anika Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Anika Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Anika Therapeutics Inc. stock shows the strong sell signal. See more of Anika Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.